178 related articles for article (PubMed ID: 37095438)
1. Meta-analysis of Osteopontin splice variants in cancer.
An Y; Fnu G; Xie C; Weber GF
BMC Cancer; 2023 Apr; 23(1):373. PubMed ID: 37095438
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.
Hao C; Wang Z; Gu Y; Jiang WG; Cheng S
Biomed Res Int; 2016; 2016():7310694. PubMed ID: 27462610
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis.
Walaszek K; Lower EE; Ziolkowski P; Weber GF
Br J Cancer; 2018 Nov; 119(10):1259-1266. PubMed ID: 30353046
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis.
Ziółkowski P; Woźniak M; Mansour A; An Y; Weber GF
Breast Cancer Res; 2022 Sep; 24(1):64. PubMed ID: 36175970
[TBL] [Abstract][Full Text] [Related]
7. The osteopontin-c splice junction is important for anchorage-independent growth.
Shen H; Weber GF
Mol Carcinog; 2014 Jun; 53(6):480-7. PubMed ID: 23359517
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin-c is a selective marker of breast cancer.
Mirza M; Shaughnessy E; Hurley JK; Vanpatten KA; Pestano GA; He B; Weber GF
Int J Cancer; 2008 Feb; 122(4):889-97. PubMed ID: 17960616
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells.
Kamalabadi-Farahani M; Atashi A; Jabbarpour Z; Aghayan SS
BMC Res Notes; 2022 Sep; 15(1):286. PubMed ID: 36064446
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
Tang X; Li J; Yu B; Su L; Yu Y; Yan M; Liu B; Zhu Z
Int J Biol Sci; 2013; 9(1):55-66. PubMed ID: 23289017
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
13. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
14. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.
Siddiqui AA; Jones E; Andrade D; Shah A; Kowalski TE; Loren DE; Chipitsyna G; Arafat HA
J Gastroenterol Hepatol; 2014 Jun; 29(6):1321-7. PubMed ID: 24548099
[TBL] [Abstract][Full Text] [Related]
16. Nuclear osteopontin-c is a prognostic breast cancer marker.
Zduniak K; Ziolkowski P; Ahlin C; Agrawal A; Agrawal S; Blomqvist C; Fjällskog ML; Weber GF
Br J Cancer; 2015 Feb; 112(4):729-38. PubMed ID: 25625274
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin splice variants are differential predictors of breast cancer treatment responses.
Zduniak K; Agrawal A; Agrawal S; Hossain MM; Ziolkowski P; Weber GF
BMC Cancer; 2016 Jul; 16():441. PubMed ID: 27400751
[TBL] [Abstract][Full Text] [Related]
18. RNA blood levels of osteopontin splice variants are cancer markers.
Hartung F; Weber GF
Springerplus; 2013 Dec; 2(1):110. PubMed ID: 23543917
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis.
Yu A; Guo K; Qin Q; Xing C; Zu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
